
A multicenter, open-label, comparative trial of two daclizumab dosing strategies vs. no antibody induction in combination with tacrolimus, mycophenolate mofetil, and steroids for the prevention of acute rejection in simultaneous kidney–pancreas transplant recipients: interim analysis
Robert J Stratta, Rita R Alloway, Ernest Hodge, Agnes Lo, for the Pancreas Investigators Vital Outcomes Trial (PIVOT) Study GroupVolume:
16
Année:
2002
Langue:
english
Pages:
9
DOI:
10.1034/j.1399-0012.2002.00108.x
Fichier:
PDF, 151 KB
english, 2002